299 filings
8-K
JNJ
Johnson & Johnson
1 May 24
Results of Operations and Financial Condition
7:00am
8-K
JNJ
Johnson & Johnson
29 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:32pm
8-K/A
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
12:16pm
8-K
JNJ
Johnson & Johnson
16 Apr 24
Johnson & Johnson Reports Q1 2024 Results
7:06am
8-K
JNJ
Johnson & Johnson
23 Jan 24
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
7:45am
8-K
rupk1gu2h4 ldh
5 Dec 23
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
4:42pm
8-K
pjm3n9jnss21e0l
5 Dec 23
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
7:52am
8-K
euwqlxudtvwoojqrku
30 Nov 23
Strengthens position in high-growth MedTech segments
4:30pm
8-K
t5ryls1s50n
27 Nov 23
Departure of Directors or Certain Officers
4:56pm
8-K
yksmp1 m7i
23 Oct 23
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
4:48pm
8-K
wqr2mves
17 Oct 23
Results of Operations and Financial Condition
7:33am
8-K
cv1w1r67fm
30 Aug 23
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
7:46am
8-K
c1xwtt d69fm4b20v
25 Aug 23
Completion of Acquisition or Disposition of Assets
5:02pm
8-K
j1n8l282lcvjt3v
28 Jul 23
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
4:08pm
8-K
soc5il8 2ixgyr5
24 Jul 23
Other Events
6:20am
8-K
ho1i1q l0y6
20 Jul 23
Results of Operations and Financial Condition
7:15am
8-K
tig00j1q69u7r2o9
8 May 23
Entry into a Material Definitive Agreement
4:23pm
8-K
91jwu vhu
28 Apr 23
Departure of Directors or Certain Officers
6:14pm
8-K
iwt3yr
18 Apr 23
Results of Operations and Financial Condition
7:29am
8-K
dqn85oyx
4 Apr 23
Regulation FD Disclosure
4:12pm